Ultrasonic surfactant nebulization with different exciting frequencies

Area of Science:

• Pulmonary Medicine
• Biomaterials Science

Background:

• Intratracheal instillation of natural lung surfactant is standard for neonatal respiratory distress syndrome and increasingly used in adults.
• Improving surfactant delivery methods is crucial for better hemodynamics, distribution, and efficiency.
• Nebulization offers potential advantages but faces technical challenges.

Purpose of the Study:

• To evaluate the efficacy of ultrasonic nebulization of lung surfactant at frequencies above 2.8 MHz.
• To determine if higher frequencies improve nebulization efficiency without altering surfactant's surface-active properties.

Main Methods:

• Surfactant aerosols were generated using ultrasonic nebulizers at exciting frequencies of 1.7, 3.3, and 4.0 MHz.
• Phospholipid content, particle size, and surface activity of the aerosol and remaining surfactant were analyzed.

Main Results:

• Increasing nebulization frequency led to a significant decrease in phospholipid content and particle size of the aerosol.
• Surface activity remained unchanged in both the generated aerosol and the surfactant left in the nebulizer.
• Higher frequencies resulted in ineffective nebulization due to substantial phospholipid loss.

Conclusions:

• Ultrasonic nebulization of surfactant suspensions is currently ineffective for therapeutic applications.
• The significant reduction in phospholipid content at higher frequencies compromises the functional integrity of the surfactant.
• Further research is needed to optimize nebulization techniques for lung surfactant delivery.